April 18, 2018
General
What is the False Claims Act Alternative Remedy Provision? When a relator brings a false claims action in the name of the Government under the False Claims Act (“FCA”), the Government may elect to pursue its claim through any alternate remedy available to the Government, including any administrative proceeding, to determine a civil money […]
April 18, 2018
General
In 2005, the State of Indiana passed the Indiana False Claims and Whistleblower Protection Act (“Indiana FCA”), its own version of the federal False Claims Act (“FCA”). The Indiana FCA allows private individuals who know about fraud to bring a qui tam case against a person or entity for submitting or causing […]
April 18, 2018
General
What is Meant by “News Media” Under the False Claims Act? Under the False Claims Act, 31 U.S.C. 3730(e)(4)(A)(iii), “the court shall dismiss an action or claim . . . unless opposed by the government, if substantially the same allegation or transaction as alleged in the action or claims were […]
April 18, 2018
General
Waiving co-payments and deductibles required under Medicare Part B is a basis for a whistleblower to bring a claim under the federal False Claims Act. About the Medicare Part B Program Title XVIII of the Social Security Act prescribes coverage requirements under Part B of the Medicare program. Medicare Part […]
April 18, 2018
General
The False Claims Act Provides Awards to Successful Whistleblowers The False Claims Act provides for an award to a qui tam plaintiff in the event the government settles a qui tam suit. If the Government settles a qui tam action brought by a whistleblower notifying the government of fraud, the whistleblower (often called a […]
April 18, 2018
General
Why be a Whistleblower? Regardless of your political persuasion, your view about big or small government, or even your position on various government programs, everyone would agree that we need to catch and reduce the amount of fraud committed on the government. Private citizens — whether as consumers, employees, patients […]
April 18, 2018
General
Pharmaceutical company GlaxoSmithKline has agreed to pay $3 billion in fines to settle criminal and civil violations. The qui tam portion of the civil lawsuit arose under the False Claims Act and is said to be worth over $1 billion. At issue in the civil suit were claims relating to the company’s medications, including […]
April 5, 2018
Canada News
APRIL 5, 2018. The Ontario Court of Appeal upheld a lower court’s decision that under absolutely no circumstance can an Ontario statutory claim for secondary market liability exceed three years in length. Yes, really. In Kaynes v. BP PLC, 2018 ONCA 337, the investor alleged that BP PLC released documents […]
February 28, 2018
Canada News
On February 28, 2018, the Commissioner of the Ontario Securities Commission refused to rubber-stamp a settlement from a former chairman, chief executive officer, and president of a publicly traded company, MDC Partners, Inc. The allegations against the former executive were that he improperly received over $10 million for personal expenses […]
February 27, 2018
News
Harold Berger was named to the Academic Life Committee of the School of Engineering and Applied Science of the University of Pennsylvania.
February 6, 2018
News
On February 6, 2018, Berger Montague attorneys Jon Lambiras and Lane Vines presented a 2-hour CLE to the Philadelphia chapter of the Association of Certified Fraud Examiners. It was attended by approximately 60 attorneys, CPAs, and fraud investigators.
January 9, 2018
Canada News
January 8, 2018. The Ontario Superior Court of Justice released an order certifying a claim against Hycroft Mining Corporation (“Hycroft”) on behalf of all investors that purchased Hycroft’s pursuant to the May 9, 2013 secondary public offering. Lawyers Eli Karp and Hadi Davarinia are advancing the proceeding into discovery towards […]